HIGHLIGHTS
- who: David Brett Erasmus et al. from the (UNIVERSITY) have published the article: Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients, in the Journal: (JOURNAL) of July/23,/2018
- what: BMSCs may be safely administered to lung transplant recipients with moderate to severe, treatment-refractory obstructive CLAD (BOS).
- how: The authors evaluated immune effector cells (NK B and Tregs) in the blood samples from 11 out of the 13 study subjects (Fig 2).
SUMMARY
In a retrospective cohort study of primary lung transplant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.